Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6490
    +0.0002 (+0.02%)
     

  • OIL

    83.38
    +0.02 (+0.02%)
     

  • GOLD

    2,338.70
    -3.40 (-0.15%)
     

  • Bitcoin AUD

    99,939.71
    -2,763.31 (-2.69%)
     

  • CMC Crypto 200

    1,414.27
    -9.83 (-0.69%)
     

  • AUD/EUR

    0.6071
    +0.0015 (+0.24%)
     

  • AUD/NZD

    1.0954
    +0.0024 (+0.22%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,564.48
    +93.01 (+0.53%)
     

  • FTSE

    8,049.92
    +5.11 (+0.06%)
     

  • Dow Jones

    38,420.32
    -83.37 (-0.22%)
     

  • DAX

    18,109.35
    -28.30 (-0.16%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

AbbVie Enters the Race to Develop New COVID-19 Treatments

Cory Renauer, The Motley Fool
·2-min read
AbbVie Enters the Race to Develop New COVID-19 Treatments

The biopharmaceutical giant is working with several partners on a monoclonal antibody treatment for the novel coronavirus.

Continue reading